|
 |
|
|
|||
|
 |
|
Apr. 6, 2017 Source: Pharmgate news release Having completed the integration of its new division, ProtaTek International, and in order to better fulfill customer needs and company objectives, Pharmgate has reorganized its management and sales team. Doug Rupp is promoted to the position of Chief Operating Officer. Doug joined the company in 2012 initially leading Regulatory Affairs, and Operations since the acquisition of the Pennfield Animal Health business. Peter Criddle who has been with the company since its inception in 2008 is promoted to Chief Financial Officer. Edward Seed has assumed the function of VP Global Marketing and International Sales and will focus on global product strategies and expanding the business internationally. Chad Howser is promoted to the position of Executive Director of Sales for the US business. All domestic sales and technical functions will report to him. Chad holds a BS degree in Marketing and after a sales career in the pharmaceutical industry, spent the last eight years in product management with ADM Alliance Nutrition. Dr. Alexander Hintz joined the company as a Technical Services Veterinarian for the eastern Corn Belt region. Alex completed his BS and DVM degrees at the Universities of Minnesota and Wisconsin respectively, and comes to Pharmgate after a brief stint in practice. Mike Mulder is appointed as Account Manager for the southern Minnesota and adjacent territory. As a long term resident of this geography, Mike has held sales positions with Zoetis, Veterinary Medical Center and a couple of pharmaceutical companies. These appointments will position the company well as it enters its next phase of expansion. About Pharmgate and Pharmgate Animal Health Pharmgate LLC, is the majority-owned US subsidiary of Jinhe Biotechnology Co., Ltd., the world leader in the production of chlortetracycline feed grade, chlortetracycline hydrochloride and salinomycin and marketer of Pennchlor, Pennox, Neo-Oxy brands and a line of swine vaccines in the USA. Pharmgate Animal Health LLC is the joint venture between Pharmgate LLC and ECO Animal Health, London U.K., a leader in the development, registration and marketing of pharmaceutical products for global animal health markets including Aivlosin, as well as a range of generic therapeutic products. Tweet |
|
|
|
|
|
|
|
|
|||||||||||||
